Is Cassava Sciences Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: SAVA) stock is to Hold SAVA stock.
Out of 1 analyst, 0 (0%) are recommending SAVA as a Strong Buy, 0 (0%) are recommending SAVA as a Buy, 1 (100%) are recommending SAVA as a Hold, 0 (0%) are recommending SAVA as a Sell, and 0 (0%) are recommending SAVA as a Strong Sell.
What is SAVA's earnings growth forecast for 2025-2025?
(NASDAQ: SAVA) Cassava Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.
Cassava Sciences's earnings in 2025 is -$24,342,000.
In 2025, SAVA is forecast to generate -$26,569,343 in earnings, with the lowest earnings forecast at -$26,569,343 and the highest earnings forecast at -$26,569,343.
What is SAVA's revenue growth forecast for 2025-2025?
(NASDAQ: SAVA) Cassava Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Cassava Sciences's revenue in 2025 is $0.
In 2025, SAVA is forecast to generate $4,830,789,600 in revenue, with the lowest revenue forecast at $4,830,789,600 and the highest revenue forecast at $4,830,789,600.
What is SAVA's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: SAVA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 35.65%.
What is SAVA's Price Target?
According to 1 Wall Street analyst that have issued a 1 year SAVA price target, the average SAVA price target is $2.00, with the highest SAVA stock price forecast at $2.00 and the lowest SAVA stock price forecast at $2.00.
The Wall Street analyst predicted that Cassava Sciences's share price could reach $2.00 by Mar 25, 2026. The average Cassava Sciences stock price prediction forecasts a potential upside of 28.21% from the current SAVA share price of $1.56.
What is SAVA's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: SAVA) Cassava Sciences's current Earnings Per Share (EPS) is -$0.53. In 2025, SAVA's EPS is forecast to hit -$0.55 (min: -$0.55, max: -$0.55).
What is SAVA's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: SAVA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.